• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卵巢透明细胞癌患者总生存和癌症特异性生存的列线图的建立与验证。

Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma.

机构信息

Department of Obstetrics and Gynecology, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, 1 ShuaiFuYuan, Wangfujing, DongCheng District, Beijing, 100730, P.R. China.

出版信息

J Ovarian Res. 2020 Oct 17;13(1):123. doi: 10.1186/s13048-020-00727-3.

DOI:10.1186/s13048-020-00727-3
PMID:33069259
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7568829/
Abstract

BACKGROUND

Ovarian clear cell carcinoma (OCCC) is a rare histologic type of ovarian cancer. There is a lack of an efficient prognostic predictive tool for OCCC in clinical work. This study aimed to construct and validate nomograms for predicting the overall survival (OS) and cancer-specific survival (CSS) in patients with OCCC.

METHODS

Data of patients with primary diagnosed OCCC in the Surveillance, Epidemiology, and End Results (SEER) database between 2010 and 2016 was extracted. Prognostic factors were evaluated with LASSO Cox regression and multivariate Cox regression analysis, which were applied to construct nomograms. The performance of the nomogram models was assessed by the concordance index (C-index), calibration plots, decision curve analysis (DCA) and risk subgroup classification. The Kaplan-Meier curves were plotted to compare survival outcomes between subgroups.

RESULTS

A total of 1541 patients from SEER registries were randomly divided into a training cohort (n = 1079) and a validation cohort (n = 462). Age, laterality, stage, lymph node (LN) dissected, organ metastasis and chemotherapy were independently and significantly associated with OS, while laterality, stage, LN dissected, organ metastasis and chemotherapy were independent risk factors for CSS. Nomograms were developed for the prediction of 3- and 5-year OS and CSS. The C-indexes for OS and CSS were 0.802[95% confidence interval (CI) 0.773-0.831] and 0.802 (0.769-0.835), respectively, in the training cohort, while 0.746 (0.691-0.801) and 0.770 (0.721-0.819), respectively, in the validation cohort. Calibration plots illustrated favorable consistency between the nomogram predicted and actual survival. C-index and DCA curves also indicated better performance of nomogram than the AJCC staging system. Significant differences were observed in the survival curves of different risk subgroups.

CONCLUSIONS

We have constructed predictive nomograms and a risk classification system to evaluate the OS and CSS of OCCC patients. They were validated to be of satisfactory predictive value, and could aid in future clinical practice.

摘要

背景

卵巢透明细胞癌(OCCC)是一种罕见的卵巢癌组织学类型。在临床工作中,OCCC 缺乏有效的预后预测工具。本研究旨在构建和验证用于预测 OCCC 患者总生存(OS)和癌症特异性生存(CSS)的列线图。

方法

从 2010 年至 2016 年的监测、流行病学和最终结果(SEER)数据库中提取原发性 OCCC 患者的数据。使用 LASSO Cox 回归和多变量 Cox 回归分析评估预后因素,并应用这些因素构建列线图。通过一致性指数(C 指数)、校准图、决策曲线分析(DCA)和风险亚组分类来评估列线图模型的性能。绘制 Kaplan-Meier 曲线比较亚组之间的生存结果。

结果

SEER 登记处的 1541 名患者被随机分为训练队列(n=1079)和验证队列(n=462)。年龄、侧别、分期、淋巴结(LN)清扫、器官转移和化疗与 OS 独立且显著相关,而侧别、分期、LN 清扫、器官转移和化疗是 CSS 的独立危险因素。建立了预测 3 年和 5 年 OS 和 CSS 的列线图。训练队列中 OS 和 CSS 的 C 指数分别为 0.802[95%置信区间(CI)0.773-0.831]和 0.802(0.769-0.835),验证队列中分别为 0.746(0.691-0.801)和 0.770(0.721-0.819)。校准图表明列线图预测的生存与实际生存具有良好的一致性。C 指数和 DCA 曲线也表明列线图的性能优于 AJCC 分期系统。不同风险亚组的生存曲线存在显著差异。

结论

我们构建了预测列线图和风险分类系统,以评估 OCCC 患者的 OS 和 CSS。验证表明它们具有令人满意的预测价值,并有助于未来的临床实践。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca5/7568829/6a4ac6c2cb8c/13048_2020_727_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca5/7568829/7c1d4fdd4c59/13048_2020_727_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca5/7568829/1174fba1e7fd/13048_2020_727_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca5/7568829/4c02436c8d64/13048_2020_727_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca5/7568829/139b6823c1a4/13048_2020_727_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca5/7568829/6a4ac6c2cb8c/13048_2020_727_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca5/7568829/7c1d4fdd4c59/13048_2020_727_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca5/7568829/1174fba1e7fd/13048_2020_727_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca5/7568829/4c02436c8d64/13048_2020_727_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca5/7568829/139b6823c1a4/13048_2020_727_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dca5/7568829/6a4ac6c2cb8c/13048_2020_727_Fig5_HTML.jpg

相似文献

1
Development and validation of Nomograms for predicting overall survival and Cancer-specific survival in patients with ovarian clear cell carcinoma.卵巢透明细胞癌患者总生存和癌症特异性生存的列线图的建立与验证。
J Ovarian Res. 2020 Oct 17;13(1):123. doi: 10.1186/s13048-020-00727-3.
2
Construction and validation of log odds of positive lymph nodes (LODDS)-based nomograms for predicting overall survival and cancer-specific survival in ovarian clear cell carcinoma patients.基于阳性淋巴结对数比值(LODDS)的列线图在预测卵巢透明细胞癌患者总生存期和癌症特异性生存期方面的构建与验证
Front Oncol. 2024 Mar 21;14:1370272. doi: 10.3389/fonc.2024.1370272. eCollection 2024.
3
Developing and validating a prognostic nomogram for ovarian clear cell carcinoma patients: A retrospective comparison of lymph node staging schemes with competing risk analysis.开发并验证卵巢透明细胞癌患者的预后列线图:基于竞争风险分析的淋巴结分期方案回顾性比较
Front Oncol. 2022 Nov 9;12:940601. doi: 10.3389/fonc.2022.940601. eCollection 2022.
4
Nomograms for predicting overall survival and cancer-specific survival in elderly patients with epithelial ovarian cancer.预测老年上皮性卵巢癌患者总生存和癌症特异性生存的列线图。
J Ovarian Res. 2023 Apr 14;16(1):75. doi: 10.1186/s13048-023-01144-y.
5
Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Young Patients with Epithelial Ovarian Cancer: Analysis Based on SEER Program.基于 SEER 计划的上皮性卵巢癌年轻患者总生存和癌症特异性生存的预测列线图分析。
Adv Ther. 2022 Jan;39(1):257-285. doi: 10.1007/s12325-021-01955-9. Epub 2021 Oct 29.
6
Development and external validation of nomograms for predicting individual survival in patients with ovarian clear cell carcinoma.列线图预测卵巢透明细胞癌患者个体生存的建立和外部验证。
Cancer Med. 2023 May;12(10):11385-11395. doi: 10.1002/cam4.5853. Epub 2023 Mar 27.
7
Exploration and prognostic analysis of two types of high-risk ovarian cancers: clear cell vs. serous carcinoma: a population-based study.两种高危型卵巢癌(透明细胞癌与浆液性癌)的探索性预后分析:一项基于人群的研究。
J Ovarian Res. 2024 Jun 1;17(1):119. doi: 10.1186/s13048-024-01435-y.
8
A prognostic model of patients with ovarian mucinous adenocarcinoma: a population-based analysis.卵巢黏液性囊腺癌患者的预后模型:基于人群的分析。
J Ovarian Res. 2022 Feb 16;15(1):26. doi: 10.1186/s13048-022-00958-6.
9
Development and evaluation of nomograms and risk stratification systems to predict the overall survival and cancer-specific survival of patients with hepatocellular carcinoma.开发和评估列线图和风险分层系统,以预测肝细胞癌患者的总生存率和癌症特异性生存率。
Clin Exp Med. 2024 Feb 28;24(1):44. doi: 10.1007/s10238-024-01296-1.
10
Development and validation of prognostic nomograms for early-onset colon cancer in different tumor locations: a population-based study.不同肿瘤部位早发性结肠癌预后列线图的建立与验证:基于人群的研究。
BMC Gastroenterol. 2023 Oct 21;23(1):362. doi: 10.1186/s12876-023-02991-1.

引用本文的文献

1
Machine learning-based prognosis prediction for serous ovarian cancer using the SEER database and data from a single center in China.利用监测、流行病学和最终结果(SEER)数据库以及来自中国某单一中心的数据,基于机器学习对浆液性卵巢癌进行预后预测。
Transl Cancer Res. 2025 Aug 31;14(8):4703-4719. doi: 10.21037/tcr-2025-540. Epub 2025 Aug 14.
2
Development and validation of a nomogram for predicting overall and cancer-specific survival in elderly patients (≥ 65 years) with epithelial ovarian cancer.用于预测老年(≥65岁)上皮性卵巢癌患者总生存期和癌症特异性生存期的列线图的开发与验证。
Eur J Med Res. 2025 Sep 1;30(1):831. doi: 10.1186/s40001-025-03114-0.
3

本文引用的文献

1
The impact of systematic retroperitoneal lymphadenectomy on long-term oncologic outcome of women with advanced ovarian clear-cell carcinoma.系统性腹膜后淋巴结清扫术对晚期卵巢透明细胞癌女性长期肿瘤学结局的影响。
J Gynecol Oncol. 2020 Jul;31(4):e47. doi: 10.3802/jgo.2020.31.e47. Epub 2020 Jan 8.
2
Precision medicine for ovarian clear cell carcinoma based on gene alterations.基于基因改变的卵巢透明细胞癌精准医学
Int J Clin Oncol. 2020 Mar;25(3):419-424. doi: 10.1007/s10147-020-01622-z. Epub 2020 Feb 4.
3
Rethinking of treatment strategies and clinical management in ovarian clear cell carcinoma.
Predicting the prognosis of epithelial ovarian cancer patients based on deep learning models.
基于深度学习模型预测上皮性卵巢癌患者的预后。
Front Oncol. 2025 Jul 25;15:1592746. doi: 10.3389/fonc.2025.1592746. eCollection 2025.
4
Development and validation of nomograms to forecast overall survival and cancer-specific survival in Asian patients diagnosed with epithelial ovarian cancer.预测亚洲上皮性卵巢癌患者总生存期和癌症特异性生存期的列线图的开发与验证
Front Surg. 2025 Mar 25;12:1443605. doi: 10.3389/fsurg.2025.1443605. eCollection 2025.
5
Development and validation of a prognostic nomogram for ovarian clear cell carcinoma: a study based on the SEER database and a Chinese cohort.卵巢透明细胞癌预后列线图的开发与验证:一项基于监测、流行病学和最终结果(SEER)数据库及中国队列的研究
Discov Oncol. 2025 Apr 7;16(1):482. doi: 10.1007/s12672-025-02272-1.
6
Prognostic models for mucinous and non-specific adeno cholangiocarcinoma: a population-based retrospective study.黏液性和非特异性腺泡胆管癌的预后模型:一项基于人群的回顾性研究。
Front Endocrinol (Lausanne). 2024 Jun 11;15:1284283. doi: 10.3389/fendo.2024.1284283. eCollection 2024.
7
Construction and validation of log odds of positive lymph nodes (LODDS)-based nomograms for predicting overall survival and cancer-specific survival in ovarian clear cell carcinoma patients.基于阳性淋巴结对数比值(LODDS)的列线图在预测卵巢透明细胞癌患者总生存期和癌症特异性生存期方面的构建与验证
Front Oncol. 2024 Mar 21;14:1370272. doi: 10.3389/fonc.2024.1370272. eCollection 2024.
8
From clinical management to personalized medicine: novel therapeutic approaches for ovarian clear cell cancer.从临床管理到个性化医学:卵巢透明细胞癌的新型治疗方法。
J Ovarian Res. 2024 Feb 12;17(1):39. doi: 10.1186/s13048-024-01359-7.
9
Progress of the application clinical prediction model in polycystic ovary syndrome.多囊卵巢综合征临床预测模型应用进展。
J Ovarian Res. 2023 Nov 25;16(1):230. doi: 10.1186/s13048-023-01310-2.
10
Clinical characteristics analysis and prognostic nomogram for predicting survival in patients with second primary prostate cancer: a population study based on SEER database.基于 SEER 数据库的人群研究:预测第二原发前列腺癌患者生存的临床特征分析和预后列线图
J Cancer Res Clin Oncol. 2023 Oct;149(13):11791-11806. doi: 10.1007/s00432-023-05086-2. Epub 2023 Jul 5.
重新思考卵巢透明细胞癌的治疗策略和临床管理。
Int J Clin Oncol. 2020 Mar;25(3):425-431. doi: 10.1007/s10147-020-01625-w. Epub 2020 Jan 27.
4
Adjuvant chemotherapy vs. observation in stage I clear cell ovarian carcinoma: A systematic review and meta-analysis.Ⅰ期透明细胞卵巢癌辅助化疗与观察比较:系统评价和荟萃分析。
Gynecol Oncol. 2020 Apr;157(1):293-298. doi: 10.1016/j.ygyno.2019.12.045. Epub 2020 Jan 21.
5
Effect of Chemotherapy, Laparoscopy, and Cytology on Stage IC Ovarian Clear Cell Carcinoma: A Long-Term, Single-Center Study.化疗、腹腔镜检查和细胞学检查对 IC 期卵巢透明细胞癌的影响:一项长期的单中心研究。
Int J Environ Res Public Health. 2020 Jan 13;17(2):491. doi: 10.3390/ijerph17020491.
6
Development and External Validation of a Nomogram for Predicting Survival in Patients With Stage IA Non-small Cell Lung Cancer ≤2 cm Undergoing Sublobectomy.预测接受亚肺叶切除术的直径≤2 cm的IA期非小细胞肺癌患者生存情况的列线图的开发与外部验证
Front Oncol. 2019 Dec 11;9:1385. doi: 10.3389/fonc.2019.01385. eCollection 2019.
7
Prognostic nomograms for predicting cause-specific survival and overall survival of stage I-III colon cancer patients: a large population-based study.预测 I-III 期结肠癌患者特定病因生存率和总生存率的预后列线图:一项基于大人群的研究。
Cancer Cell Int. 2019 Dec 27;19:355. doi: 10.1186/s12935-019-1079-4. eCollection 2019.
8
A nomogram to predict prognosis of patients with unresected hepatocellular carcinoma undergoing radiotherapy: a population-based study.预测未切除肝细胞癌患者放疗预后的列线图:一项基于人群的研究。
J Cancer. 2019 Jul 25;10(19):4564-4573. doi: 10.7150/jca.30365. eCollection 2019.
9
Prognostic Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Patients with Major Salivary Gland Mucoepidermoid Carcinoma.预测大唾液腺黏液表皮样癌患者总生存期和癌症特异性生存期的预后列线图
J Cancer. 2019 Jul 22;10(18):4380-4388. doi: 10.7150/jca.27992. eCollection 2019.
10
Construction and validation of a nomogram to predict overall survival in patients with inflammatory breast cancer.构建并验证预测炎性乳腺癌患者总生存的列线图。
Cancer Med. 2019 Sep;8(12):5600-5608. doi: 10.1002/cam4.2470. Epub 2019 Aug 12.